NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/12/2024
Voltar para busca
Dado oficial do USPTO
NOVORIG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
65
Atualização mais recente
31/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 44
Data de depósito
13/08/2020
Data de registro
31/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/12/2024
Última transação
31/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Kitchener, Ontario, CA
Examinador
ROSEN, BENJAMIN
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Rapid Novor Inc.
Representantes
Jeffrey B. Sladkus, Esq. The Sladkus Law Group
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Proteomics analysis test kits comprising reagents for detectingquantifying and characterizing antibody proteins in a biological sample for scientific research purposes
Classe 5
Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancerautoimmune diseases and infections
Classe 44
Providing medical diagnostic and prognostic testing for cancerautoimmune diseases and infectionsthe medical analysisevaluationreporting of test results to help healthcare professionals determine a patient's clinical diagnosisthe effectiveness of treatmentsto revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Publicações
Histórico de despachos e eventos da marca no USPTO.
65 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
31/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2024
PUBO
PUBLISHED FOR OPPOSITION
12/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/09/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
20/09/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
28/08/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
28/08/2024
CNSI
SUSPENSION INQUIRY WRITTEN
28/08/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/12/2023
GNSL
LETTER OF SUSPENSION E-MAILED
08/12/2023
CNSL
SUSPENSION LETTER WRITTEN
08/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/12/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
23/10/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
23/10/2023
CNSI
SUSPENSION INQUIRY WRITTEN
23/10/2023
DOCK
ASSIGNED TO EXAMINER
23/10/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
17/10/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/03/2023
GNSL
LETTER OF SUSPENSION E-MAILED
13/03/2023
CNSL
SUSPENSION LETTER WRITTEN
13/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2023
ALIE
ASSIGNED TO LIE
10/03/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/03/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
16/12/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
16/12/2022
CNSI
SUSPENSION INQUIRY WRITTEN
16/12/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/06/2022
GNSL
LETTER OF SUSPENSION E-MAILED
01/06/2022
CNSL
SUSPENSION LETTER WRITTEN
01/06/2022
DMCC
DATA MODIFICATION COMPLETED
01/06/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
31/05/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
31/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2022
DRRR
DIVISIONAL REQUEST RECEIVED
03/05/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
03/05/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/05/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/11/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/11/2021
CNSI
SUSPENSION INQUIRY WRITTEN
05/11/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/05/2021
GNSL
LETTER OF SUSPENSION E-MAILED
05/05/2021
CNSL
SUSPENSION LETTER WRITTEN
05/05/2021
DOCK
ASSIGNED TO EXAMINER
12/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/03/2021
ALIE
ASSIGNED TO LIE
18/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/12/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/12/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/12/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/12/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/12/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/12/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/12/2020
GNRT
NON-FINAL ACTION E-MAILED
08/12/2020
CNRT
NON-FINAL ACTION WRITTEN
08/12/2020
DOCK
ASSIGNED TO EXAMINER
08/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/09/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NOVORIG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.